MedPath

Safety evaluation of an excessive consumption of test food: a randomized, double-blind, placebo-controlled trial

Not Applicable
Conditions
Hyperglycemia
Registration Number
JPRN-UMIN000045063
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects with milk allergy or lactose intolerance 2. Subjects who were diagnosed with diabetes by the screening test 3. Sever systemic diseases affecting the results of this study 4. Subjects who have chronic illness and who take medication everyday 5. Subjects who were judged unsuitable as subjects by clinical examination at the screening test 6. Subjects who donated blood of more than 200 mL within a month or more than 400 mL within 3 months 7. Subjects who drink a lot of alcohol 8. Subjects who have been drug dependency 9. Subjects who participated in other clinical trials within one month before the agreement of participants in this study 10. Subjects in pregnancy or in nursing 11. Subjects who are judged as unsuitable for the study by the investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hematologic test, blood biochemistry test, urine analysis, blood pressure/pulsation, weight/body mass index, doctor's questions, and adverse event (Evaluate at points of 2 week and 4 week of ingestion and 2 weeks after the end of ingestion period)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath